These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS. Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924 [Abstract] [Full Text] [Related]
6. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. Nie X, Tan J, Dai Y, Liu Y, Zou J, Sun J, Ye S, Shen C, Fan L, Chen J, Bian JS. J Mol Cell Cardiol; 2018 Mar 25; 116():41-56. PubMed ID: 29374556 [Abstract] [Full Text] [Related]
7. HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension. Lin Q, Fan C, Gomez-Arroyo J, Van Raemdonck K, Meuchel LW, Skinner JT, Everett AD, Fang X, Macdonald AA, Yamaji-Kegan K, Johns RA. Arterioscler Thromb Vasc Biol; 2019 Dec 25; 39(12):2505-2519. PubMed ID: 31597444 [Abstract] [Full Text] [Related]
11. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling. Zhang Y, Peng B, Han Y. Biomed Pharmacother; 2018 Jul 25; 103():1279-1286. PubMed ID: 29864909 [Abstract] [Full Text] [Related]
12. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target. Kikuchi N, Satoh K, Kurosawa R, Yaoita N, Elias-Al-Mamun M, Siddique MAH, Omura J, Satoh T, Nogi M, Sunamura S, Miyata S, Saito Y, Hoshikawa Y, Okada Y, Shimokawa H. Circulation; 2018 Aug 07; 138(6):600-623. PubMed ID: 29636330 [Abstract] [Full Text] [Related]
18. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats. Tang M, Wang R, Feng P, Dong Q, Chen W, Zhao Y, Li A, Li H, Chen J, Huang W. J Cardiovasc Pharmacol; 2020 Sep 01; 76(3):337-348. PubMed ID: 32569012 [Abstract] [Full Text] [Related]
19. Network of MicroRNAs Mediate Translational Repression of Bone Morphogenetic Protein Receptor-2: Involvement in HIV-Associated Pulmonary Vascular Remodeling. Chinnappan M, Mohan A, Agarwal S, Dalvi P, Dhillon NK. J Am Heart Assoc; 2018 Feb 25; 7(5):. PubMed ID: 29478969 [Abstract] [Full Text] [Related]
20. HMGB1 is mechanistically essential in the development of experimental pulmonary hypertension. Dai M, Xiao R, Cai L, Ge T, Zhu L, Hu Q. Am J Physiol Cell Physiol; 2019 Feb 01; 316(2):C175-C185. PubMed ID: 30517029 [Abstract] [Full Text] [Related] Page: [Next] [New Search]